World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
64
Citations
16644
World Ranking
2592
National Ranking
195

Bertrand Lell publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Bertrand Lell sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 265 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 234 scientists 205–214 publications: 208 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 233 publications — 60th percentile

60% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Bertrand Lell D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Bertrand Lell sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 112 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 123 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 94 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 64 D-Index — 54th percentile

54% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Bertrand Lell is affiliated with the University of Tübingen in Germany and has contributed extensively to the field of medicine, with a particular focus on infectious diseases, parasitology, and public health. Their research spans areas such as mosquito-borne diseases and control, malaria research and control, and interactions between parasites and hosts.

The scientist's work includes involvement in studies on viral infections and vectors, as well as global maternal and child health, epidemiology, and pediatrics and perinatology. The main fields of study include:

  • Medicine

Subfields within their research predominantly cover:

  • Public Health, Environmental and Occupational Health
  • Infectious Diseases
  • Parasitology
  • Pediatrics, Perinatology and Child Health
  • Epidemiology

Key topics Bertrand Lell has worked on are:

  • Mosquito-borne diseases and control
  • Parasites and Host Interactions
  • Malaria Research and Control
  • Global Maternal and Child Health
  • Viral Infections and Vectors
  • Parasite Biology and Host Interactions
  • SARS-CoV-2 and COVID-19 Research

The scientist has published in various academic venues, with frequent contributions to:

  • PLoS Neglected Tropical Diseases
  • International Journal of Infectious Diseases
  • Infection
  • BMC Medicine
  • BMC Infectious Diseases

Recent papers include:

  • "COVID-19 in Africa: Dampening the storm?", 2020, Science
  • "The duration of chemoprophylaxis against malaria after treatment with artesunate-amodiaquine and artemether-lumefantrine and the effects of pfmdr1 86Y and pfcrt 76T: a meta-analysis of individual patient data", 2020, BMC Medicine
  • "Systems analysis and controlled malaria infection in Europeans and Africans elucidate naturally acquired immunity", 2021, Nature Immunology
  • "Surveillance of the major pathogenic arboviruses of public health concern in Gabon, Central Africa: increased risk of West Nile virus and dengue virus infections", 2021, BMC Infectious Diseases
  • "Epidemiology of Schistosomiasis and Soil-Transmitted Helminth Coinfections among Schoolchildren Living in Lambaréné, Gabon", 2020, American Journal of Tropical Medicine and Hygiene

These publications display engagement with parasitology, epidemiology of tropical diseases, and infectious disease surveillance.

Bertrand Lell's frequent co-authors include:

  • Ayôla Akim Adégnika
  • Sélidji Todagbé Agnandji
  • Peter G. Kremsner
  • Michael Ramharter
  • Ghyslain Mombo-Ngoma

Best Publications

  • First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children.

    Selidji Todagbe Agnandji;Bertrand Lell;Bertrand Lell;Solange Solmeheim Soulanoudjingar;Solange Solmeheim Soulanoudjingar

  • Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial.

    Emmanuel B. Bache;Selidji Todagbe Agnandji;Bertrand Lell;José Francisco Fernandes

  • Decreased atopy in children infected with Schistosoma haematobium: a role for parasite-induced interleukin-10.

    Anita H. J. Van Den Biggelaar;Ronald Van Ree;Laura C. Rodrigues;Bertrand Lell

  • A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants.

    Selidji Todagbe Agnandji;Selidji Todagbe Agnandji;Bertrand Lell;Bertrand Lell;José Francisco Fernandes;José Francisco Fernandes

  • Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe

    Selidji T Agnandji;Angela Huttner;Madeleine E Zinser;Patricia Njuguna

  • Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine

    Daniel E Neafsey;Michal Juraska;Trevor Bedford;David Benkeser

  • Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial.

    M. Adjuik;P. Agnamey;A. Babiker;S. Borrmann;S. Borrmann

  • Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial

    Michael T. White;Robert Verity;Jamie T. Griffin;Kwaku Poku Asante

  • Interferon-γ Responses Are Associated with Resistance to Reinfection with Plasmodium falciparum in Young African Children

    Adrian J. F. Luty;Bertrand Lell;Ruprecht Schmidt-Ott;Leopold G. Lehman

  • Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials

    John J Aponte;David Schellenberg;Andrea Egan;Alasdair Breckenridge

  • Low Interleukin-12 Activity in Severe Plasmodium falciparum Malaria

    A. J. F. Luty;D. J. Perkins;B. Lell;B. Lell;B. Lell;R. Schmidt-Ott;R. Schmidt-Ott

  • Fosmidomycin, a Novel Chemotherapeutic Agent for Malaria

    Bertrand Lell;Bertrand Lell;Ronnatrai Ruangweerayut;Jochen Wiesner;Michel Anoumou Missinou;Michel Anoumou Missinou

  • Fosmidomycin for malaria

    Michel A Missinou;Steffen Borrmann;Steffen Borrmann;Andreas Schindler;Andreas Schindler;Saadou Issifou;Saadou Issifou

  • The Role of Red Blood Cell Polymorphisms in Resistance and Susceptibility to Malaria

    Bertrand Lell;Jürgen May;Ruprecht J. Schmidt-Ott;Leopold G. Lehman

  • Polymorphism in promoter region of inducible nitric oxide synthase gene and protection against malaria

    Jürgen Fj Kun;Jürgen Fj Kun;Benjamin Mordmüller;Benjamin Mordmüller;Bertrand Lell;Bertrand Lell;Leopold G Lehman;Leopold G Lehman

  • Clindamycin as an antimalarial drug: review of clinical trials.

    Bertrand Lell;Bertrand Lell;Peter G. Kremsner;Peter G. Kremsner

  • Merozoite surface antigen 1 and 2 genotypes and rosetting of Plasmodium falciparum in severe and mild malaria in Lambaréné, Gabon

    Jürgen F.T. Kun;Ruprecht J. Schmidt-Ott;Ruprecht J. Schmidt-Ott;Leopold G. Lehman;Leopold G. Lehman;Bertrand Lell;Bertrand Lell;Bertrand Lell

  • Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial

    Kwaku Poku Asante;Salim Abdulla;Selidji Agnandji;Selidji Agnandji;John Lyimo

  • COVID-19 in Africa: Dampening the storm?

    Moustapha Mbow;Bertrand Lell;Simon P. Jochems;Badara Cisse

  • Gametocyte carriage in uncomplicated Plasmodium falciparum malaria following treatment with artemisinin combination therapy: a systematic review and meta-analysis of individual patient data

    S. Abdulla;J. Achan;I. Adam;B.H. Alemayehu

  • A Head-to-Head Comparison of Four Artemisinin-Based Combinations for Treating Uncomplicated Malaria in African Children: A Randomized Trial

    Daniel Atwine;Betty Balikagala;Quique Bassat;Victor Chalwe

  • The Effect of Dosing Regimens on the Antimalarial Efficacy of Dihydroartemisinin-Piperaquine: A Pooled Analysis of Individual Patient Data

    Jane Achan;Ishag Adam;Emmanuel Arinaitwe;Elizabeth A. Ashley

  • Placental Malaria Increases Malaria Risk in the First 30 Months of Life

    Norbert G. Schwarz;Norbert G. Schwarz;Ayola A. Adegnika;Ayola A. Adegnika;Ayola A. Adegnika;Lutz P. Breitling;Lutz P. Breitling;Julian Gabor;Julian Gabor

  • Plasma Interleukin-10: Tumor Necrosis Factor (TNF)—α Ratio Is Associated with TNF Promoter Variants and Predicts Malarial Complications

    Jürgen May;Jürgen May;Bertrand Lell;Adrian J. F. Luty;Christian G. Meyer

  • High Prevalence of Asymptomatic Plasmodium falciparum Infection in Gabonese Adults

    Matthias P. Dal-Bianco;Kai B. Köster;Ulrich D. Kombila;Jürgen F. J. Kun

  • A phase 2b randomized, controlled trial of the efficacy of the GMZ2 malaria vaccine in African children.

    Sodiomon B Sirima;Benjamin Mordmüller;Paul Milligan;Ulysse Ateba Ngoa

  • Molecular analysis of recrudescent parasites in a Plasmodium falciparum drug efficacy trial in Gabon

    L.C. Ranford-Cartwright;J. Taylor;T. Umasunthar;L.H. Taylor

Frequent Co-Authors

Peter G. Kremsner
Peter G. Kremsner University of Tübingen
Ayola A. Adegnika
Ayola A. Adegnika University of Tübingen
Saadou Issifou
Saadou Issifou University of Tübingen
Martin P. Grobusch
Martin P. Grobusch University of Amsterdam
Benjamin Mordmüller
Benjamin Mordmüller Radboud University Medical Center
Marcel Tanner
Marcel Tanner Swiss Tropical and Public Health Institute
Steffen Borrmann
Steffen Borrmann University of Tübingen
Maria Yazdanbakhsh
Maria Yazdanbakhsh Leiden University Medical Center
Clara Menéndez
Clara Menéndez University of Barcelona
Quique Bassat
Quique Bassat University of Barcelona

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Microbiology, exploring related online degrees can broaden career opportunities in healthcare and research. Health information management, for example, is a rapidly growing field where professionals manage patient data and health systems. Interested learners may consider the best online cahiim accredited health information management degree programs to ensure high-quality education that meets industry standards.

For those looking for a faster entry into the healthcare administration side, obtaining certification through the quickest medical billing and coding certificate online programs can be an efficient pathway. These certificates equip students with essential skills for medical billing, coding, and healthcare documentation.

Beyond traditional microbiology degrees, there are also diverse options in medical degrees online. These programs provide flexibility for students who wish to pursue degrees in various medical fields while balancing other commitments.

For graduates aiming at public health, identifying which online mph programs are easiest to get into can be helpful for admission success. An MPH can complement microbiology expertise by focusing on community health, epidemiology, and disease prevention, opening doors to leadership roles in public health sectors.

Best Scientists Citing Bertrand Lell

Trending Scientists

Recently Published Articles